Erythroid Promoter Confines FGF2 Expression to the Marrow after Hematopoietic Stem Cell Gene Therapy and Leads to Enhanced Endosteal Bone Formation
Fibroblast growth factor-2 (FGF2) has been demonstrated to be a promising osteogenic factor for treating osteoporosis. Our earlier study shows that transplantation of mouse Sca-1+ hematopoietic stem/progenitor cells that are engineered to express a modified FGF2 leads to considerable endosteal/trabe...
Main Authors: | Meng, Xianmei, Baylink, David J., Sheng, Matilda, Wang, Hongjie, Gridley, Daila S., Lau, K.-H. William, Zhang, Xiao-Bing |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356341/ |
Similar Items
-
Intra-Bone Marrow Transplantation of Endosteal Bone Marrow Cells Facilitates Allogeneic Hematopoietic and Stromal Cells Engraftment Dependent on Early Expression of CXCL-12
by: Chen, Chen, et al.
Published: (2015) -
Vascularised endosteal bone tissue in armoured sauropod dinosaurs
by: Chinsamy, Anusuya, et al.
Published: (2016) -
A quantitative assessment of the content of hematopoietic stem cells in mouse and human endosteal-bone marrow: a simple and rapid method for the isolation of mouse central bone marrow
by: Mahajan, Maya M., et al.
Published: (2015) -
Bone Marrow Endosteal Mesenchymal Progenitors Depend on HIF Factors for Maintenance and Regulation of Hematopoiesis
by: Guarnerio, Jlenia, et al.
Published: (2014) -
Changes in the distribution and function of leukocytes after whole-body iron ion irradiation
by: Gridley, Daila S., et al.
Published: (2016)